FDA Inspection
Pfizer Healthcare India Private LimitedPfizer Healthcare India Private Limited – FDA Inspection, Oct 18, 2022
Record Details
This FDA Inspection record concerns Pfizer Healthcare India Private Limited, with an inspection on October 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 18, 2022
- Product Type
- Drugs
View Company Profile
ID · f7adf7eb-8fa7-4607-a49a-cd847f06d612
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1181610
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer Healthcare India Private Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 10, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| September 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Healthcare India Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.